ARYA Sciences Acquisition Corp V, traded under the ticker ARYE, is a blank-check company sponsored by Perceptive Advisors, the New York-based healthcare-focused investment firm that has launched multiple SPAC vehicles under the ARYA Sciences banner. Targeting the life sciences and biotechnology sector, ARYE completed its initial public offering in 2021 as part of Perceptive's systematic approach to identifying and merging with emerging biopharmaceutical and medical technology companies. On July 28, 2023, the company filed a Form 15-12G with the SEC, voluntarily terminating its registration under Section 12(g) of the Securities Exchange Act, indicating the vehicle concluded its life cycle without completing a business combination. Investors and analysts tracking the full history of ARYE and the broader ARYA Sciences SPAC family can access comprehensive filing data, timeline analytics, and sponsor performance metrics by signing up at SpacDesk.